JP2014532760A5 - - Google Patents

Download PDF

Info

Publication number
JP2014532760A5
JP2014532760A5 JP2014541013A JP2014541013A JP2014532760A5 JP 2014532760 A5 JP2014532760 A5 JP 2014532760A5 JP 2014541013 A JP2014541013 A JP 2014541013A JP 2014541013 A JP2014541013 A JP 2014541013A JP 2014532760 A5 JP2014532760 A5 JP 2014532760A5
Authority
JP
Japan
Prior art keywords
compound
agent
acceptable salt
formula
uric acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2014541013A
Other languages
English (en)
Japanese (ja)
Other versions
JP6008974B2 (ja
JP2014532760A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2011/059433 external-priority patent/WO2013066353A1/en
Publication of JP2014532760A publication Critical patent/JP2014532760A/ja
Publication of JP2014532760A5 publication Critical patent/JP2014532760A5/ja
Application granted granted Critical
Publication of JP6008974B2 publication Critical patent/JP6008974B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2014541013A 2011-11-04 2011-11-04 痛風発赤の治療方法 Expired - Fee Related JP6008974B2 (ja)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US2011/059433 WO2013066353A1 (en) 2011-11-04 2011-11-04 Methods for treating gout flares

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2016178714A Division JP6192142B2 (ja) 2016-09-13 2016-09-13 痛風発赤の治療方法

Publications (3)

Publication Number Publication Date
JP2014532760A JP2014532760A (ja) 2014-12-08
JP2014532760A5 true JP2014532760A5 (enExample) 2015-01-22
JP6008974B2 JP6008974B2 (ja) 2016-10-19

Family

ID=48192537

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2014541013A Expired - Fee Related JP6008974B2 (ja) 2011-11-04 2011-11-04 痛風発赤の治療方法

Country Status (18)

Country Link
EP (1) EP2775836B8 (enExample)
JP (1) JP6008974B2 (enExample)
KR (1) KR101848121B1 (enExample)
CN (2) CN109045009A (enExample)
AU (1) AU2011380510B2 (enExample)
BR (1) BR112014010729A2 (enExample)
CA (1) CA2859693C (enExample)
CL (1) CL2014001157A1 (enExample)
DK (1) DK2775836T3 (enExample)
EA (1) EA201490928A1 (enExample)
ES (1) ES2698396T3 (enExample)
IL (1) IL232384A (enExample)
MX (1) MX357510B (enExample)
NZ (1) NZ624726A (enExample)
PH (1) PH12014500990A1 (enExample)
PL (1) PL2775836T3 (enExample)
SG (1) SG11201401981TA (enExample)
WO (1) WO2013066353A1 (enExample)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1871874B1 (en) 2005-04-11 2015-04-08 Crealta Pharmaceuticals LLC Variant forms of urate oxidase and use thereof
RU2535038C2 (ru) 2009-06-25 2014-12-10 Криэлта Фармасьютикалз ЭлЭлСи Способы и наборы для прогнозирования риска инфузионных реакций и опосредованной антителами потери ответа при терапии пэгилированной уриказой с помощью мониторинга содержания мочевой кислоты в сыворотке крови
EP2640461B1 (en) 2010-11-16 2019-06-19 The Board Of Trustees Of The Leland Stanford Junior University Systems for treatment of dry eye
CN104602686A (zh) * 2012-04-13 2015-05-06 西玛贝医药公司 利用卤芬酯或卤芬酸以及抗炎剂治疗痛风患者中高尿酸血症的方法
CN110234340A (zh) * 2016-11-11 2019-09-13 好利恩风湿病制药有限责任公司 泼尼松和尿酸酶分子的组合疗法及其用途
EP3701952A4 (en) * 2017-10-26 2021-06-30 Otsuka Pharmaceutical Co., Ltd. INOSITE PHOSPHATE COMPOSITION
CN109223707B (zh) * 2018-09-13 2020-12-08 中国药科大学 一种尿酸酶外用凝胶制剂、其制备方法及用途
WO2020160325A1 (en) 2019-01-30 2020-08-06 Horizon Pharma Rheumatology Llc Reducing immunogenicity to pegloticase
CN114028584B (zh) * 2021-11-18 2023-09-05 辽宁万嘉医药科技有限公司 一种降尿酸的多酚多元环糊精包合物及其制备方法
US12269875B2 (en) 2023-08-03 2025-04-08 Jeff R. Peterson Gout flare prevention methods using IL-1BETA blockers
KR20250085216A (ko) 2023-12-05 2025-06-12 인제대학교 산학협력단 알코올 스프레이를 활용한 환자 냉각장치

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6262118B1 (en) * 1999-06-04 2001-07-17 Metabolex, Inc. Use of (-) (3-trihalomethylphenoxy) (4-halophenyl) acetic acid derivatives for treatment of insulin resistance, type 2 diabetes and hyperlipidemia
US6624194B1 (en) 1999-06-04 2003-09-23 Metabolex, Inc. Use of (−) (3-trihalomethylphenoxy) (4-halophenyl) acetic acid derivatives for treatment of insulin resistance, type 2 diabetes, hyperlipidemia and hyperuricemia
EP1865954A4 (en) * 2005-03-21 2010-12-15 Metabolex Inc METHOD FOR AVOIDING OEDEM IN THE TREATMENT OR PREVENTION OF DISEASES AFFECTING PPAR GAMMA INCLUDING CANCER
EA201270666A1 (ru) * 2007-11-27 2012-12-28 Ардеа Биосайнсиз Инк. Соединения и фармацевтические композиции для снижения уровня мочевой кислоты
RU2522458C2 (ru) * 2008-04-30 2014-07-10 Веллстат Терапьютикс Корпорейшн Тетразольные соединения для снижения концентрации мочевой кислоты

Similar Documents

Publication Publication Date Title
JP2014532760A5 (enExample)
JP2012184234A5 (enExample)
JP2013528650A5 (enExample)
JP2017513836A5 (enExample)
US10537570B2 (en) Use of pimobendan for the reduction of heart size and/or the delay of onset of clinical symptoms in patients with asymptomatic heart failure due to mitral valve disease
JP2014532726A5 (enExample)
JP2011006480A5 (enExample)
JP2013528655A5 (enExample)
EP2775836B1 (en) Methods for treating gout flares
JP5978216B2 (ja) テオフィリンとフェブキソスタットの併用療法のための方法
WO2014065275A1 (ja) 腫瘍融解症候群の治療薬及び予防薬
US20180117042A1 (en) Methods for treating respiratory syncytial virus infection
JP2014505107A5 (enExample)
TW201908298A (zh) 胺烷基苯並硫氮呯衍生物之用途
WO2015025226A2 (en) Compositions and therapeutic methods for accelerated plaque regression
KR20140095078A (ko) 3,4-이치환된 피리딘 화합물, 이의 사용 방법 및 이를 포함하는 조성물
JP2019507791A5 (enExample)
JP2013087119A5 (enExample)
RU2014115733A (ru) Новая соль и медицинское применение
JP6202633B2 (ja) ハロフェナートまたはハロフェン酸および第2の尿酸低下薬を用いる痛風に罹っている患者の高尿酸血症の治療方法
JP2014532759A5 (enExample)
US20230233514A1 (en) Antiviral compounds and methods of using the same
JP2014532758A5 (enExample)
US20180214420A1 (en) Methods for treating hyperuricemia in patients with gout using halofenate or halofenic acid and a second urate-lowering agent
JP6047172B2 (ja) 患者部分集団における痛風の治療方法